Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
In the Lab
STAT+

The Parker Institute looks to grow, leveraging outside donors and equity stakes

  • Rebecca Robbins

By Rebecca Robbins July 9, 2019

Reprints
Parker book
In conversations with potential donors, Sean Parker and his team have started handing out a book telling PICI’s story. Alissa Ambrose/STAT

LOS ANGELES — Internet billionaire Sean Parker has spent hundreds of millions of dollars of his fortune — and almost entirely his fortune alone — in an effort to build a new model for developing treatments that harness the immune system to fight cancer.

Now, his Parker Institute for Cancer Immunotherapy is increasingly looking to sources of funding beyond Parker himself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
In Philadelphia, ‘tranq’ is leaving drug users with horrific…
In Philadelphia, ‘tranq’ is leaving drug users with horrific wounds. Other communities are bracing for the…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Oscar Health names former Aetna executive as new CEO
Oscar Health names former Aetna executive as new CEO
Pharmalittle: Ohio attorney general accuses PBMs of price fixing;…
Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price…
With new study data, Intra-Cellular could expand use of…
With new study data, Intra-Cellular could expand use of approved mood-disorder treatment

Recommended Stories